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ABSTRACT 
Congenital heart diseases (CHD) are the leading cause of infant mortality and 
morbidity. Defects of the outflow tract (OFT) make up a large percentage of human 
CHD. In my study, I focused on the role of Bone morphogenetic protein (BMP) on heart 
development. I investigated Bmp signaling in OFT development using conditional 
knocking out Bmps, including Bmp2, -4 and -7. Deletion of Bmp4/7 in second heart field 
(SHF) results in persistent truncus arteriosus (PTA), which is caused by endothelial to 
mesenchyme transition (EMT) defect. I found that Vegfa (vascular endothelial growth 
factor a) is a downstream target of Bmp and miR-17-92. Repression of Vegfa in OFT is 
important for the proper onset of EMT at E10.5. Further exploration on Bmp2/4/7 
mutation indicates that loss of Bmp signal disrupt the smooth muscle differentiation and 
maintenance. Similar with observations on Marfan syndrome mouse model, Bmp2/4/7 
triple CKO embryos exhibited significant upregulation of Tgf-β signal activity. 
Alternation of SMC feature is likely due to the persistence of Isl-1 expression.  
Haploinsufficiency of Bmp4 triggered early onset of aorta aneurysm in Fbn-1
C1039G/+
 
mice.  These data indicate that Bmps not only play an important role in embryonic 
cardiogenesis, but also are critical for the cell fate differentiation and maintenance in 
adulthood. 
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NOMENCLATURE 
AAA                    Abdominal Aorta Aneurysm 
AP                       Aorta-Pulmonary 
AVC                    Atrioventricular Canal 
BMP                    Bone Morphogenetic Protein 
CDK                    Cyclin-Dependent Kinase 
CHD                    Congenital Heart Disease 
ChIP                    Chromatin Immunoprecipitation 
CKO                    Conditional Knock Out 
CNC                    Cardiac Neural Crest 
ECM                    Extracellular Matrix 
EMT                    Endothelial to Mesenchyme Transition 
FBN                     Fibrillin 
FDA                     Food and Drug Administration 
JNK                      c-Jun N-terminal Kinase 
LAP                      Latency Associated Peptide 
LLC                      Large Latent Complex 
LTBP                    Latent Tgf-β Binding Protein 
MFS                      Marfan Syndrome 
miR                       microRNA 
OFT                      Outflow Tract 
PFA                       Paraformaldehyde 
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PHF                       Primary Heart Field 
PPE                       Pancreatic Elastase 
PTA                       Persistent Truncus Arteriosus 
SBE                       Smad Binding Element 
SHF                       Second Heart Field 
SLC                       Small Latent Complex 
SMAD                   Small Mothers Against Decapentaplegic 
SMC                      Smooth Muscle Cell 
TAA                      Thoracic Aorta Aneurysm 
TGF-β                   Transforming Growth Factor β 
THF                       Tertiary Heart Field 
UTR                       Untranslated Region 
VEGFA                  Vascular Endothelial Growth Factor A 
VSD                       Ventricular Septum Defect 
VV                         Vasa Vasorum 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
Congenital heart diseases (CHD) occur in nearly 1% of all live births and are the 
leading cause of infant mortality and morbidity in the western world. Anomaly of OFT 
occurs at a frequency of approximately 1/3 of congenital heart diseases. Disturbance of 
the morphogenetic patterning of the anterior pole of the heart is a cause for a variety of 
OFT defects, while this patterning is essential for separation of systemic and pulmonary 
circulations. Persistent truncus arteriosus (PTA) is a most severe phenotype of OFT 
defect, with unfavorable prognosis since complete surgical repair is not always possible 
(Williams et al., 1999). Ventricular septal defect (VSD) is always associated with PTA 
defect (Fig. 1), open heart surgery is needed if the opening is large to prevent serious 
problem. Though robust studies of possible genetics causes would provide insight into 
the pathogenesis of CHD, but, the etiology of most CHD, including OFT defects remains 
unknown because of the multifactorial nature of the diseases (Bruneau, 2008; Olson, 
2006; Yamagishi et al., 2009; Zhao and Srivastava, 2007). 
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As the first formed and functional organ in vertebrates, the heart has a pivotal 
role in distribution of nutrients and oxygen to support normal embryogenesis and 
development. At the earliest stage of cardiogenesis (E7.5), cardiac crescent, there are 
two groups of cardiac precursors exist: the primary heart field (PHF) and the second 
heart field (SHF) (Fig. 2). The PHF will eventually contribute to the left ventricle part of 
atriums and right ventricle. The SHF will give rise to the OFT, right ventricle and 
portion of atrium (Brand, 2003; Harvey, 2002; Koshiba-Takeuchi et al., 2009). Cardiac 
Neural Crest (CNC) is also involved in parts of hearts. Recent study discovered the 
tertiary heart field (THF) in chicken embryo, which is responsible for the cardiac 
 
Figure 1. Persistent truncus arteriosus. Persistent  truncus arteriosus (PTA) is a 
common congenital heart defect of OFT. As showing in this cartoon, patient has one 
large artery instead of separated aorta and pulmonary artery. VSD is associated with 
PTA defect. Diagram from American heart association website. 
http://www.heart.org/HEARTORG/Conditions/CongenitalHeartDefects/AboutConge
nitalHeartDefects/Truncus-Arteriosus_UCM_307040_Article.jsp 
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pacemaker cells, a discrete region of mesoderm outside of PHF and SHF(Bressan et al., 
2013). The linear heart tube starts beating at E8.0, and after looping process, the heart 
 
 
finally form four chambers around E10.0. The heart tube is composed of a contractile 
myocardium, an inner lining endothelium and cardiac jelly in between. The OFT first 
originates as a cardiomyocyte-lined vascular channel through which blood exits the 
primitive ventricle and fills the aortic sac (Vincentz et al., 2008). At E10.5, the OFT 
cushion is invaded by mesenchymal cells, which delaminate from the endocardium and 
undergo an epithelial-mesenchymal transformation (EMT) characterized by the 
expression of α-smooth muscle actin. As development proceeds, continued expansion of  
 
 
Figure 2. Heart fields in mouse embryo cardiogenesis. First heart field (FHF) is 
marked as pink and second heart field (SHF) is in blue. FHF will eventually give rise 
to left ventricle, part of atrium, while SHF will contribute to right ventricle, outflow 
tract and portial of atrium. Cardiac neural crest (CNC) is also believed to be involved 
in the distal part of OFT development.  Modified from http://www.ibdm.univ-
mrs.fr/equipe/genetic-control-of-heart-development/ 
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these mesenchymal cells is critical for both aorta-pulmonary (AP) septation and valve 
formation (Fig. 3). At E14.5, the mouse heart develops into four chambers and the OFT 
is separated into aorta and pulmonary artery. Further remodeling of migrating 
mesenchymal cells will transforms cushions into fibrous leaflets. Atrioventricular (mitral 
and tricuspid, left and right respectively) and semilunar (aorta and pulmonary) valves 
have different morphology and individual morphogenesis. Semilunar valves can prevent  
backflow of the blood from the aorta and pulmonary trunks into the ventricles (Délot et 
al., 2003). The cardiac neural crest also contributes to the AP septum and the OFT 
cushions, it is destined to distal OFT according to recent reports (Liu et al., 2004).  EMT 
process is also occurred at AV canal at around E9.5, which is indispensable for the 
 
 
Figure 3. Epithelial-mesenchymal transformation. During the EMT process, signals 
from myocardium tell the endocardium cells to delaminate, migrate and invade into the 
cardiac jelly, to form cushion mesenchyme. Those cushion mesenchyme will 
eventually contribute to valve formation, septation of the OFT, and the interventricular 
septum. EMT occurs at OFT around E10.5, and AVC around E9.5. 
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development of AV cushion formation and subsequently heart septum and associated 
valves to transit heart tube to chamber organ. 
Bone morphogenetic proteins (BMPs) are growth factors and cytokines. Bmps 
belong to TGF-β (Transforming growth factor β) super family. These proteins are active 
as homo- or heterodimer, linked by a single disulfide bond. Based on the sequence 
similarities, TGF-β family can be subdivided into TGF-β, Activin, Nodal and Bmp. 
Despite the diversity of TGF-β members in the whole animal kingdom, all members of 
the super family share similar structure and scheme of synthesis. Firstly, TGF-β is 
synthesized as a large precursor protein with N-terminal region called the mature TGF-β 
and the C-terminal pro-region referred to latency-associated peptide (LAP). A dimer of 
the C-terminal peptide is either released or associated with the mature TGF-β to form a 
latent complex, which binds to latent TGF-β binding protein (LTBPs). The presence of 
LAP facilitates transit of TGF-β from the cell to matrix and keeps the TGF-β ligand 
biologically inactive state (Khalil, 1999). Secondly, this complex will be catalyzed by 
proteinases such as plasmin, releasing of active TGF-β from LAP and resulting in the 
activation of TGF-β ligands. Activated TGF-β ligands bind to constitutively 
phosphorylated type II receptors through extracellular domain, resulting recruitment and 
transphosphorylation of type I receptors. TGF-β signal pathway effector, R-Smad 
(Smad1/5/8 for BMP signal pathway and Smad2/3 for TGF-β), will be recruited and 
phosphorylated to dimerism with Co-smad (smad4). This complex will shuttle from 
cytoplasm to nucleus to execute their roles in transcriptional regulation. In the nucleus, 
Smads modulate transcription of target genes by direct binding to DNA, interaction with 
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other DNA-binding proteins, or recruiting co-activators/repressors (Kawabata et al., 
1998) (Fig. 4). Phospho-Smad has been shown to regulate transcription in both positive 
and negative way (Kawabata et al., 1998). A c-terminal phosphatase can de-
phosphorylate R-smad to terminate the signaling cascade. However, it is reported that  
there is constant cytoplasm-nucleus shuttling of R-Smad and Co-Smad which is 
independent on phosphorylation signal. Besides, CDK8/9 is reported to phosphorylate 
 
Figure 4. Bone morphogenetic protein signal pathway. Diagram shows BMP 
signal pathway and its involvement of microRNA biogenesis. Upon binding to Bmp 
receptor II, Bmp ligands phosphorylate Bmp receptor I and activate R-smad. R-
smad/Smad4 complex regulate its target genes by co-transfactors. Smad/p68/Drosha 
is reported to facilitate cropping of pri-miRNA to pre-miRNA.  
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the linker region of Smad protein, which recruits YAP and subsequent transcription 
regulation (Alarcon et al., 2009) (Fig. 4).  
It is reported that Smads alone can directly binding to certain DNA motifs, but 
with low affinity and selectivity (Itoh et al., 2000; Karaulanov et al., 2004; Shi and 
Massagué, 2003; Zwijsen et al., 2003). Therefore, to ensure its regulation of its target 
gene, Smads have to associate with various transcription factors to form R-Smad/Co-
Smad/Co-TF complex (Zwijsen et al., 2003). R-Smads and Smad4 can recognize Smad 
binding element (SBE) motif GTCTG (Shi, 1998). GCAT was described as a Smad1 
binding element in the promoter of Xenopus Vent2 (Henningfeld et al., 2000). GCCG 
core consensus is believed to be Smad binding motif in several vertebrate BMP-
responsive promoters, such as Smad6 (Ishida et al., 2000) and Id1 (Korchynskyi and ten 
Dijke, 2002). Karaulanov et al. identified TGGCGCC, a BMP-responsive element, is 
highly prognostic for BMP-responsive enhancers  (Karaulanov et al., 2004). 
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CHAPTER II 
BMP SIGNALING REPRESSES VEGFA TO PROMOTE OUTFLOW TRACT 
CUSHION DEVELOPMENT

 
 
Background and Significance 
BMPs are named by their ability to induce bone and cartilage formation. There 
are about over 20 different BMPs have been identified in various species (Hogan, 1996). 
Excitingly but not surprisingly, recombinant BMP2 and BMP7 are approved by the Food 
and Drug Administration (FDA) in the clinical use of spine fusion, fracture healing and 
oral surgery (Nakashima and Reddi, 2003; Reddi, 1998). Besides bone formation, BMPs 
are also involved in morphogenesis of different organs and pathological processes. 
Studies show that BMPs are required for the OFT morphogenesis and BMP knock-out 
mice have a cushion defect phenotype during cardiogenesis (Liu et al., 2004). Bmp2/4 
bind to BMPR-IA and BMPR-IB, Bmp6/7 strongly bind to ALK-2, but weakly to 
BMPR-IB (Kawabata et al., 1998; Miyazono et al., 2010). Diversity of receptors, 
different binding affinity and preference make BMP signaling complex. During 
development, BMPs and their receptors are expressed at many sites in which epithelial 
mesenchymal interactions occur, suggesting that BMPs play critical roles in early 
embryogenesis and organogenesis (Jones et al., 1991; Zhang and Bradley, 1996). 
                                                          

 This work has been published in Development. Bai, Y., Wang, J., Morikawa, Y., Bonilla-Claudio, M., 
Klysik, E., and Martin, J.F. (2013). Bmp signaling represses Vegfa to promote outflow tract cushion 
development. Development 140, 3395-3402. 
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Bmp4 is expressed in splanchnic and branchial arch mesoderm, which contribute 
to the OFT and right ventricle development. Nkx2.5-Cre conditional ablation of Bmp4 
resulted in defects of the OFT septation, myocardium differentiation and assembly of 
vascular smooth muscle to vessels (Liu et al., 2004). Bmp2 is involved in AV cushion 
development and essential for the invasive EMT (Luna-Zurita et al., 2010; Ma et al., 
2005). Bmp7 is less characterized and its single knock-out has no phenotype due to BMP 
functional redundancy. The Bmp4 mutant embryos show variability in phenotype and 
incomplete penetrance, possibly due to functional redundancy of Bmp ligands. Although 
ablation of Bmp7 has no obvious phenotypic consequences in the hearts (Solloway and 
Robertson, 1999), loss of Bmp4 causes up-regulation of Bmp7 in OFT myocardium and 
compound mutants have a more severe phenotype (Liu et al., 2004).  Overlapping 
expression of the Bmp ligands in the OFT and their function redundancy makes 
functional analysis of Bmp ligands in OFT development challenging.  
Wnt1-Cre derived deficiency of type I Bmp receptors, Alk2 and Alk3, results in 
severe OFT defects, with the Cre activity in CNC (Kaartinen et al., 2004; Stottmann et 
al., 2004). Ablation of Bmp type 1 receptor a (Bmpr1a) under Tie2-Cre in endocardium 
caused failure of cushion formation, suggesting that Bmp signal is pivotal for cushion 
forming endocardium to undergo EMT process (Stottmann et al., 2004).  Analysis of a 
hypomorphic allele of the ubiquitously expressed Bmp type II receptor (Bmpr2), lacking 
half of the ligand-binding domain, revealed defective proximal OFT septation in mouse 
embryos (Délot et al., 2003).   
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Recent studies have shown that Bmp signaling also regulates downstream genes 
through miRNA maturation. In vascular smooth muscle, TGF-β- and BMP-specific 
SMAD is recruited to p68 (DDX5) RNA helicase containing complex. The SMAD/p68 
complex interacts with Drosha in the nucleus to regulate miRNA biogenesis of a subset 
of miRNAs. This complex get access to pri-miR-21 to regulate miR-21 biogenesis 
(Davis et al., 2008). During cardiac development, Bmp2/4 regulate the OFT myocardial 
differentiation by promoting transcription of the miR-17-92 cluster (Wang et al., 2010). 
The miR-17-92 cluster encodes six miRNAs, miR-17, miR-18a, miR-19a, miR-20a, 
miR19b-1 and miR-92-1. They are known as oncogenes and play roles in the 
development of heart, lungs and immune system (Koralov et al., 2008; Ventura et al., 
2008; Vincentz et al., 2008; Xiao et al., 2008). 
In this study, we discovered that loss of Bmp4/7 in SHF resulted in PTA with up-
regulation of Vegfa, repression of which is required in the atrioventricular canal (AVC) 
to promote EMT (Chang et al., 2004). Our in vitro studies showed that Vegfa was 
repressed by both Smad and miR-17/20a. Moreover, in vivo and ex vivo studies showed 
overexpression of miR-17-92 or repression of Vegfa can partially suppress the Bmp loss 
of function phenotype. Our study reveals that in the OFT EMT and CNC influx is 
regulated by Bmp via a combination of Smad- and miR-dependent Vegfa repression. 
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Materials and Methods 
Mouse lines 
The Bmp4 flox, miR-17-92 null and miR-17-92
OE 
alleles and Mef2c-Cre lines 
have been previously described (Liu et al., 2004; Ventura et al., 2008; Verzi et al., 2005; 
Xiao et al., 2008). To generate the Bmp7flox allele, a targeting vector was constructed 
that introduced one loxP site into upstream of the Bmp7 fourth exon followed by a frt 
flanked PGKneo cassette while another loxP site was introduced into downstream of the 
Bmp7 fourth exon (See A-1). miR- 17-92 LacZ transgenic mice is previously described 
(Wang et al., 2013). 
β-galactosidase staining, histology, and immunostaining 
Embryos were fixed overnight in 4% PFA (paraformaldehyde) or buffered 
formalin, dehydrated through graded ethanol, and paraffin embedded. Sections were cut 
at 7 µm and used for H&E staining or immunostaining. LacZ expression on whole 
embryos was performed as previously described (Lu et al., 1999). For Twist1 
immunodetection, sections were deparaffinized and hydrated. And 10 mM citrate buffer 
was used for antigens retrieval. Monoclonal anti-Twist1 (1:200 dilution) (abcam, 
ab50887) was used as primary antibody. HRP-conjugated anti-mouse secondary 
antibody (Bio-Rad Co., Hercules, CA) was used and visualized using TSA
TM
 plus 
Fluorescence Systems from PerkinElmer (Boston, MA). Nuclei were stained with 4',6-
Diamidino-2-Phenylindole, Dihydrochloride (Dapi) (invitrogen).  
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Quantitative real time RT-PCR  
Total RNA from OFT (E10.5 embryos) was isolated using the RNeasy Micro Kit 
(QIAGEN). SuperScript II Reverse Transcriptase (Invitrogen) was used for RT-PCR 
with 20 ng-100 ng of mRNA, and SYBR Green JumpStart Taq ReadyMix (Sigma) was 
used for real time thermal cycling in triplicate reactions on StepOnePlus Real-Time PCR 
system (ABI); Gapdh was used as internal control. Vegfa was detected by TaqMan 
Probe (IDT, Mm.PT.47.7135538.g) and 18s rRNA (IDT) as internal control. For 
miRNAs, TaqMan microRNA assay kits (Applied Biosystems) were used according to 
manufacturer’s guidelines. Sno-202 was used as internal control. All error bars represent 
SEM. For all qRT-PCR experiments, at least 4 mutants and 4 controls embryos were 
analyzed. Primer sequences are available in A-2. 
Sequence analysis and miRNA target predictions 
For sequence analysis and alignment, NCBI (http://www.ncbi.nlm.nih.gov/), 
Ensemble (http://uswest.ensemble.org/Mus_musculus/Info/Index), rVista 2.0 
(http://rvista.dcode.org/), and TFSEARCH 
(http://mbs.cbrc.jp/research/db/TFSEARCH.html) were used. For miRNA targets 
predictions, miRanda (http://www.microrna.org), TargetScan (http://www.targetscan.org) 
and miRDB (http://mirdb.org/miRDB/) were used.  
Generation of constructs  
To generate Vegfa promoter luciferase reporter plasmid, 1563 bp of Vegfa 
promoter was amplified using a high-fidelity PCR system (Roche) and subcloned into 
pGL3-Basic vector (Promega). To generate Vegfa 3’UTR luciferase reporter plasmid, 
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1881 bp Vegfa 3’UTR genomic sequence was amplified using a high-fidelity PCR 
system (Roche) from cDNA clone (#6816435, Open Biosystems) and subcloned into the 
pMIR-REPORT
TM
 Luciferase miRNA Expression Reporter Vector (Ambion). Site-
directed mutagenesis of the seed sites in Vegfa 3’UTR and Vegfa promoter were 
performed with QuickChange II Site-Directed Mutagenesis Kit (Stratagene). All primers 
are available in A-2.  
Luciferase activity assay  
P19 cells were transfected with promoter and 3’UTR reporter plasmids 
described above using Lipofectamine 2000 (Invitrogen). Luciferase activity assays were 
performed using the Dual-Luciferase® Reporter assay system (Promega). The renilla 
luciferase encoding plasmid pRL-TK is used as normalization control. Ca-Alk3 (Wang 
et al., 2010) was used to activate Smad-pathway. miRNA mimics were purchased from 
Thermo Scientific. 
Ex vivo OFT explant culture 
A solution (1.5 mg/ml) of rat-tail collagen type I (BD Biosciences) was 
dispensed into 24 well microculture dishes and allowed to solidify inside a 37 °C, 5% 
CO2 incubator. Collagen gels were washed several times with DMEM containing 10% 
FBS, 0.1% insulin-transferrin-seleniun (ITS, GIBCO; Invitrogen), and streptomycin 
(Invitrogen). OFTs were harvested in sterile Tyrode’s Salt Solution (Sigma-Aldrich) 
from E10.5 embryos. OFT were carefully dissected, and endocardium was exposed to 
the collagen gel, with myocardium overlaying. 4 hours after attachment, medium (100 
μl/well) was added and explants cultured for up to 3 days. Explants were fixed and 
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stained with α-SMA-Cyan3 (1:100; Sigma-Aldrich) to detected mesenchymal cells and 
phalloidin-FITC (1:100; Sigma-Aldrich) to reveal the actin cytoskeleton as described 
(Luna-Zurita et al., 2010). TO-PRO®-3 Iodide (TOP3) (invitrogen) was used for nuclei 
staining. For explants treatments, the medium was supplemented with sFlt (10 ng/ml; 
R&D system 471-F1). Medium was replaced every 24 hours.  
In vivo chromatin immunoprecipitation  
About 80 OFT of E10.5 wild type embryos were dissected and subject to the 
chromatin immunoprecipitation (ChIP) analysis, soluble chromatin was prepared after 
formaldehyde crosslinking and sonication. Smad1/5/8 antibody (sc-6031 X, Santa Cruz) 
was used to immmunoprecipitate protein-bound DNA fragments. And normal rabbit 
immunoglobulin G was used as control. The PCR product for SBE1 fragment was 280bp, 
402bp for SBE2 fragment, and 204bp for SBE3 fragment. Primers designed for 
irrelevant chromatin sequence to Smad were used as a negative control. SYBR is used 
for ChIP-qPCR and result is analyzed by percent input method described before. Primer 
sequences are available in A-2. 
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Results 
Bmp2, -4, and -7 regulate EMT and have redundant functions 
Bmp2, -4, and -7 show overlapping expression pattern and functional redundancy 
(Bonilla-Claudio et al., 2012; Dudley and Robertson, 1997; Furuta et al., 1997; Wang et 
al., 2010). We compared the expression patterns of Bmp2, -4 , -7 using lacZ knock-in 
mouse lines for Bmp2 and Bmp4 and in situ hybridization of Bmp7. Bmp2 and Bmp4 
were expressed in the OFT at E9.5, while Bmp7 was broadly expressed in entire heart 
tube (A-3, A-B,G-H,M-N). Bmp4 expression was found in inflow tract at E9.5 but was 
limited to OFT at E10.5. Analysis of the sections revealed that Bmp2, -4, and -7 were 
exclusively co-expressed in OFT myocardium (A-3, C,E,I,L,O,R). At E10.5, expression 
of Bmp2 in the OFT was decreased (A-3, G,J), while Bmp4 and Bmp7 expression were 
maintained at similar levels (A-3, A,D and M,P).   
To determine redundant functions of Bmp molecules, we deleted Bmp2, -4 and -7 
in different combinations in the OFT using Mef2c-Cre (Fig. 5A-H). Proximal OFT 
mesenchymal cells of Bmp2/4, Bmp4/7 and Bmp2/7 dCKO were absent (Fig. 5C-F). 
Bmp4 and Bmp7 deletion resulted in OFT cushion defect in CNC-derived distal OFT, as 
well as, proximal OFT (Fig. 5D). The distal OFT defects were not observed by deleting 
Bmp2 in Bmp4 homozygous or heterozygous background, suggesting that Bmp2 had 
restricted OFT function (Fig. 5C,F).  
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Figure. 5  Inactivation of Bmp2, -4, and -7 in SHF.  A-H: Sagittal sections of 
E10.5 embryos with different combination of Bmps deletion. Bmps were knocked out 
conditionally in SHF using Mef2c-Cre. Black arrowheads show proximal OFT and 
white arrowheads show distal OFT.  Scale bar=100 µm. n=6, 5, 5, 6, 3, 2, 5, 5, 
corresponding to A-H. I-L: Whole mount hearts and sections of control and Bmp4/7 
dCKO at E14.5. Arrow in top panel represents PTA. ba: branchial arch; m: 
myocardium; mc: mesenchymal cushion; e: epithelium; ao: aorta; pa: pulmonary 
artery; la: left atrium; ra: right atrium; lv: left ventricle; rv: right ventricle; av: aorta 
valve; sv: semilunar valve; pta: persistent truncus arteriosus; ivs: interventricular 
septum; scale bar=100 µm (white), scale bar=500 µm (red). M-N: Immunostaining 
of Twist1 in control and Bmp4/7 dCKO embryos at E10.5. Arrow points twist1 
positive cells, scale bar=50 µm. O: Expression of EMT related genes were examined 
in the OFT of control and Bmp4/7 dCKO embryos at E10.5. RT-PCR analysis was 
performed using SYBR for Id1/2, snai1 and slug and Taqman for Vegfa (Control 
n=5, mutant n=4).  p-value was analyzed by t-test (two-tailed). Error bars represent 
SEM. *<0.004, **=0.03, ***=0.04.  
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Consistent with the defective CNC influx and proximal EMT observed at E10.5,   
Bmp4/7 double mutants had severe OFT defects at E14.5 with failure of OFT separation 
resulting in PTA (Table 1, Fig. 5I-L). One Bmp4/7 dCKO had double outlet right 
ventricle (DORV), with both aortic and pulmonary arteries draining the right ventricle 
(Table 1). In addition to defective great vessel separation, histological sections showed 
the hypoplastic semilunar valves and interventricular septal defect (VSD, data not shown) 
in Bmp4/7 dCKO (Fig. 5J,L). Taken together, our findings revealed that Bmp4 and Bmp7 
had redundant functions in OFT development. To further explore Bmp-signaling in the 
OFT, we focused on Bmp4/7 dCKO mouse model. 
 
 
 
Figure 5 Continued. 
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Table 1  Defects observed in Bmp2/4/7 conditional knockout embryos at E14.5 
             OFT defects 
Genotype    PTA  DORV 
Mef2c-Cre;Bmp4/7
f/f
             6/7  1/7 
Mef2c-Cre;BMP2
f/+
BMP4/7
f/f                   
5/5  n/a
 
Mef2c-Cre;Bmp2/4/7
f/f
  6/6  n/a 
DORV: double outlet right ventricle, PTA: persistent truncus arteriosus 
 
 
To investigate EMT process in Bmp4/7 dCKO, we performed pHH3 analysis 
for cell proliferation and did not see obvious difference between control and Bmp4/7 
dCKO in the myocardium (data not shown). Immunostaining showed fewer Twist1 
expressing mesenchymal cells in the OFT of Bmp4/7 dCKO than the control (Fig. 5M-
N), indicating that fewer cells progressed through EMT in the Bmp4/7 mutant. To 
determine the mechanism of EMT regulation by Bmp, expression of the genes involved 
in Bmp pathway and EMT were examined by qRT-PCR. The Bmp-regulated EMT genes, 
Snai1, Slug, Id1 and Id2 were significantly decreased in Bmp4/7 dCKO OFT while 
Vegfa was up-regulated by 1.8-fold (Fig. 5O).  
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Smad directly represses Vegfa transcription 
The major downstream Bmp-signaling effectors are Smad proteins. To determine 
if Vegfa is a direct downstream target of Bmp, we searched for conserved Smad binding 
sites in Vegfa 5’ upstream sequences by bioinformatics analysis.  Analysis of Vegfa 5’ 
upstream sequence predicted several conserved functional elements for Bmp response 
(McCulley et al., 2008) which are Smad binding elements (SBE) and Smad1 binding 
motif (s1). SBE motif is a canonical Smad binding sequence (Shi, 1998) and is found in 
the promoter of many TGF-β and Bmp responsive genes while the s1 motif is another 
sequence found in the promoter of Xenopus vent2. These motifs are usually flanked with 
BRE-like (Bmp Responsive Element) and/or GC-rich Boxes (Fig. 6A) which is common 
in regulatory elements of Bmp responsive genes. To test whether Smad directly binds 
Vegfa 5’upstream sequences, we performed in vivo chromatin immunoprecipitation 
(ChIP)-PCR analysis on wild-type E10.5 embryonic OFT.  We detected enrichment in 
the anti-Smad1/5/8 ChIP-PCR for all three putative SBEs (Fig. 6B, C).  ChIP-qPCR data 
further supported that those putative SBEs in Vegfa chromatin were bound by Smad (Fig. 
6C).  The results indicate that Smad1/5/8 can directly bind Vegfa chromatin in the OFT.   
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Figure. 6  Transcription modulation of Vegfa by Smad.  A: Putative TF binding sites 
by Smad in Vegfa 5’ upstream sequence. Mutations introduced in luciferase reporter 
assay are shown in red. B: Relative positions of ChIP primers in Vegfa chromatin are 
shown in arrows.  s1: Smad1 binding motif, SBE: Smad binding element. C: in vivo 
ChIP indicates the bound of Smad to Vegfa chromatin. DNA from wild type OFT was 
immunoprecipitated with antibody against Smad1/5/8. Non-specific rabbit IgG were 
used as negative control. Unimmunoprecipitated DNA (10% input) was used as positive 
control. Each sample was analyzed with PCR amplification using primer sets shown in 
panel B. ddH2O represents the PCR analysis in absence of template DNA. Bar graph on 
the right is ChIP-qPCR, showing percent input of IgG and anti-Smad. Each sample is 
triplicate. Error bars represent SEM. D: Native and mutated Vegfa reporter constructs. E: 
Luciferase assay. Native and mutated Vegfa reporter constructs were transfected with or 
without Ca-Alk3 construct. *=0.011, **=0.009.  Error bars represent SEM. 
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Figure 6 Continued.  
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To further determine if Smad directly regulated Vegfa transcription, we cloned 
approximately 1500 bp upstream of Vegfa and generated a luciferase reporter (Fig. 6D). 
To activate Smad-dependent Bmp pathway, we co-transfected a constitutive active form 
of the type 1 Bmp receptor Alk3, ca-Alk3 into p19 cell line (Wang et al., 2010). 
Luciferase assays demonstrated that Vegfa promoter activity was significantly 
diminished by 35% in the presence of ca-ALK3 (Fig.6E).  To demonstrate if Vegfa 
promoter repression was due to direct Smad binding, we introduced mutations in the 
predicted Smad binding sites (Fig. 6D). Mutations in SBE1, 2, and/or 3 resulted in loss 
of repression activity by Bmp signaling (Fig. 6E), showing that Smad directly binds 
these sites and represses Vegfa.  Mutation in s1 did not change luciferase activity (Fig. 
6E), indicating that this motif may not be necessary in repressing Vegfa.  The results 
indicated that Smad can directly repress Vegfa transcription, however, by only 35%. 
Since loss of Bmp4/7 resulted in 175% increase in Vegfa levels, there may be other 
important Smad elements that are excluded from our luciferase reporter or other Bmp 
downstream effector mechanisms that contribute to Vegfa regulation.  
MiR-17 and -20a are downstream effectors of Bmp in Vegfa repression 
Our results raise the possibility that Vegfa levels are regulated by mechanisms 
other than direct Smad-binding to Vegfa chromatin. Alternative downstream Bmp 
effectors are microRNAs, which are involved in refinement of gene expression. miR-17-
92 is downstream of Bmp pathway in cardiac development (Wang et al., 2010).  
Bioinformatic analysis predicted a highly conserved miR-17/20a binding site in 3’UTR 
of Vegfa (Fig. 7A).  The levels of pri-miR-17-92 and mature miR-17/miR-20a were 
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decreased in the OFT of Bmp4/7 dCKO embryos (Fig. 7B), showing that miR-17/miR-
20a were downstream of Bmp4/7.  
To determine the role of miR-17-92 during OFT development, we analyzed miR-
17-92
N/N
 embryos. At E10.5 (Fig. 7C, D), miR-17-92
N/N 
embryos showed OFT defects 
including lack of mesenchymal cushion formation.  In both proximal and distal OFT, 
miR-17-92
N/N 
embryos developed no mesenchymal cells, resembling the phenotype of 
Bmp4/7 dCKO. At E14.5, miR-17-92
N/N
 exhibited DORV phenotype, together with 
abnormal semilunar valve and VSD (Fig. 7E-F). Notably, loss of miR-17-92 resulted in 
1.7-fold increase in the level of Vegfa (Fig. 7G).  This up-regulation of Vegfa was 
similar to what was observed in Bmp4/7 dCKO (Fig. 7O). Taken together, our results 
suggest that miR-17-92 is downstream of Bmp signaling during EMT process in OFT.   
To determine if Vegfa can be regulated by miR-17 and -20a, we cloned 1874 bp 
native Vegfa 3’UTR and constructed luciferase reporter vector (Fig. 7H). Co-transfection 
with miR-17/20a resulted in suppression of Vegfa 3’UTR reporter (Fig. 7I), while miR-
92a did not suppress the luciferase activity.  Then we mutated miR-17/20a binding site 
of Vegfa 3’UTR (Fig. 7H).  Suppression by both miR-17 and -20a was abolished in 
mutated Vegfa reporter (Fig. 7I), showing that the putative miR-17/20a site was 
responsible for 3’UTR silencing of Vegfa.  The results strongly suggest that miR-17/20a 
are downstream effectors of Bmp4/7 in repression of Vegfa. 
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Figure. 7  miR-17/20a are downstream effectors of Bmp signaling.  A: Analysis of 
Vegfa 3’UTR reveals a highly conserved miR-17/20a binding site. Mmu: mouse, Hsa: 
human, Ptr: chimpanzee, Rno: rat, Ocu: rabbit. B: qRT-PCR analysis of pri-miR-17-92, 
miR-17 and miR-20a in the OFT of Bmp4/7 dCKO embryos. *=0.049, **=0.027. Error 
bars represent SEM. (Control n=5, mutant n=3) C-F: Histological analysis on miR-17-92 
null embryos at E10.5 (C, D) and E14.5 (E, F). Black arrowheads show proximal EMT 
defect at E10.5 (D). White arrowheads show distal EMT defect (D) and abnormal 
semilunar valve at E14.5 (F). ba: branchial arch; m: myocardium; mc: mesenchymal 
cushion; e: epithelium; ao: aorta; pa: pulmonary artery; la: left atrium; ra: right atrium; lv: 
left ventricle; rv: right ventricle; av: aorta valve; sv: semilunar valve; ivs: 
interventricular septum G: qRT-PCR analysis of Vegfa in the OFT of miR-17-92 mutant. 
For each qRT-PCR (control n=4, mutant n=4), P-value was analyzed by t-test (two-
tailed). *=0.046. Error bars represent SEM H: (Top) miR-17/20a seed sequences on 
Vegfa 3’UTR. (Middle) miR luciferase reporter construct. (Bottom) Mutation of seed 
sequences. I: Luciferase assay. The assay was performed by transfecting reporter 
construct and miR-17 or -20a.  miR-92a was used as a negative control. P-value was 
analyzed by t-test (two-tailed). *=0.032, **=0.009. Error bars represent SEM.  
 
 
 
 
 
25 
 
Repression of Vegfa regulates EMT process during OFT development 
Vegfa inhibits mesenchymal transformation in the AV cushion (Chang et al., 
2004), however, the potential roles of Vegfa in EMT process during Bmp-mediated OFT 
development have not been investigated. To determine if Bmp regulate EMT through 
Vegfa repression, we investigated if reducing Vegfa can rescue EMT caused by Bmp4/7 
deletion.  We performed ex vivo analysis by culturing the OFT from E10.5 embryos on 
collagen gel, with the endocardium exposed to the gel (Fig. 8A). In control explants, a 
halo of mesenchymal cells formed around the myocardium, with non-invasive 
mesenchymal cells on the surface of gel and invasive mesenchymal cells invading the 
collagen depths (Fig. 8B, C).  In the OFT of Bmp4/7 dCKO, both invasive and 
noninvasive EMT were absent (Fig. 8D, E).  Administration of sFlt, a soluble Vegfa 
antagonist, partially suppressed mesenchymal transformation defect in Bmp4/7 dCKO by 
rescuing the non-invasive mesenchyme cells formation (Fig. 8F). Invasive EMT was not 
rescued by antagonizing Vegfa (Fig. 8G), suggesting this process is regulated by other 
downstream Bmp targets, such as Snail.  
Next, to determine if miR-17 and 20a regulate EMT through Vegfa regulation, 
we performed explant culture from miR-17-92
N/N 
OFT (Fig. 8H, I). The OFT from miR-
17-92 null lacked both invasive and noninvasive EMT (Fig. 8H, I), which recapitulated 
the explant from Bmp4/7 dCKO (Fig. 8D). After addition of the Vegfa antagonist sFlt to 
the explant, both non-invasive and invasive EMT process was rescued in the miR-17-92 
n/n explants (Fig. 8J, K), showing that Vegfa down-regulation was sufficient to rescue 
miR-17-92 loss of function phenotype. Since antagonizing Vegfa was not sufficient to 
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rescue invasive EMT in the explant from Bmp4/7 (Fig. 8G), regulation of Vegfa by miR-
17-92 was one of multiple downstream effectors of Bmp signaling.   
 
 
 
Figure. 8 Ex vivo collagen gel assay of the OFT. A: Diagram illustration of the OFT 
explant culture on collagen gel. The OFT from E10.5 embryo was dissected, cut, and 
placed on the collagen gel. Inner endocardium layer (shown in green) was exposed to the 
gel, with myocardium (shown in blue) on the top. B-K: EMT assays on the OFT of 
control, Bmp4/7 dCKO, and miR-17-92 null embryos. EMT was visualized by Phalloidin 
to outline the cell shape and by alpha-SMA immunostaining to stain mesenchymal cells. 
TOP3 was used to stain nuclei. Invasive EMT is observed on the surface of collagen gel, 
(Top panels, Arrows) and non-invasive EMT is observed in the gel (Bottom panels, 
Arrowheads).  Scale bar=100 µm. 
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Figure. 9 Rescue of Bmp4/7 deficiency by conditionally overexpressing miR-17-92. 
A: qPCR analysis on miR-17, 20a and Vegfa on the OFT of miR-17-92
OE/+
 embryos. 
miR-106b is used as negative control. *=0.016, **=0.033, (Control n=4, mutant n=4) 
Expression of Vegfa in miR17-92
OE/+
 embryos. *=0.047. B: qRT-PCR analysis of Vegfa 
on Bmp4/7 dCKO and miR17-92
OE/+
 (Control n=6, Bmp4/7 mutant n=5, mutant n=3).  p-
value was analyzed by t-test (two-tailed). *=0.045, **=0.048. Error bars represent SEM. 
C-F: Histological analysis on the embryos of Bmp4/7 dCKO and miR-17-92 
overexpression OFT at E10.5. Black arrowheads show proximal OFT mesenchymal cells, 
white arrowheads point distal OFT mesenchymal cells. ba: branchial arch; m: 
myocardium; mc: mesenchymal cushion; e: epithelium; Scale bar=100 µm.  
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MiR-17-92 can rescue defects in EMT caused by loss of Bmp 
To address the hypothesis that miR-17/20a are  direct downstream effectors of 
Bmp in EMT process in vivo, we overexpressed miR-17-92 in the Bmp4/7 dCKO by 
crossing miR-17-92
OE/+ 
(Xiao et al., 2008) and Mef2c-Cre lines.  qRT-PCR data showed 
that miR-17  and miR-20a were mildly elevated by approximately 1.3 fold in the OFT of 
Mef2c-Cre;miR-17-92
OE/+ 
(Fig. 9A). Vegfa levels were also moderately down-regulated 
in the OFT of Mef2c-Cre;miR-17-92
OE/+ 
(Fig. 9A), demonstrating that miR-17-92 
repressed Vegfa in vivo.  To determine if miR-17-92 can compensate for the loss of 
Bmp4/7, we generated Mef2c-Cre;Bmp4/7
f/f
;miR-17-92
OE/+ 
embryos. Mesenchymal 
cushion formation was observed in the OFT of Mef2c-Cre;Bmp4/7
f/f
;miR-17-92
OE/+ 
embryos (Fig. 9E-F): proximal cushion-forming cells were observed in 83% of the 
embryos while distal cushion cells were observed in all embryos (Table 2). At E14.5, the 
valve defect of Bmp4/7  dCKO embryos was rescued by overexpression of miR-17-92, 
while OFT septation was partially rescued in distal part (data not shown). The level of 
Vegfa in Mef2c-Cre;Bmp4/7
f/f
;miR-17-92
OE/+ 
was decreased compared to Mef2c-
Cre;Bmp4/7
f/f
 and comparable to that of control embryos (Fig. 9B), suggesting that 
suppression of Vegfa by Bmp was mediated by miR-17 and 20a.  These results strongly 
suggest that miR-17 and 20a are downstream effectors of Bmp signal during OFT 
development.   
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Table 2  OFT phenotype in Bmp4/7 mutant 
                   OFT mesenchyme present 
Genotype           Proximal OFT  Distal OFT 
Mef2c-Cre;Bmp4/7
f/f
                1/17         6/17 
Mef2c-Cre;Bmp4/7
f/f
;miR17-92
OE/+    
5/6         6/6
 
 
Although cushion formation was observed in Mef2c-Cre;Bmp4/7
f/f
;miR-17-
92
OE/+ 
embryos, mesenchymal cushion-forming cells were fewer in the rescued embryos 
indicating partial suppression (Fig. 9C-F). In addition, the extent of mesenchymal 
cushion formation was variable (Fig. 9C-F, Table 2). Together these data support the 
hypothesis that Bmp signals are mediated by the other effector mechanisms in addition 
to miR-17.   
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Discussion 
Our data uncover a direct interaction between the Bmp and Vegfa signaling 
pathways important for normal OFT development. Moreover, our findings uncover a 
mechanism to tightly modulate Vegfa activity levels in OFT.  Our results also provide 
new insight into the mechanism for coordinated development of CNC and endocardial 
cells as they contribute to the conotruncal cushions. Lastly, our data reveal that miR-17-
92 indirectly, via non-autonomous mechanisms, regulates cardiac neural crest 
development in addition to SHF derived tissues.  
Coordinated regulation of cushion formation derived from multiple cell types 
The conotruncal cushions are derived from both CNC and the endocardium. 
Bmp-signaling has been implicated previously in EMT within the atrioventricular canal 
AVC. We now show that Bmp-signaling is also important for EMT within OFT. 
Previous data in the AVC indicate that Bmp regulates genes such as Twist and Snai1 to 
promote EMT and while we did not focus on that mechanism here, it is likely that 
similar mechanisms are at work in both OFT and AVC. Our finding that Bmp signaling 
negatively regulates Vegfa in OFT provides important insight into the coordinated 
regulation of the OFT cushions.  In the OFT, in contrast to AVC, there are three separate 
tissues developing in close proximity: myocardium, endocardium, and CNC. We provide 
evidence that the Bmp-miR-17-92 mediated Vegfa repression is a critical mechanism to 
ensure coordinated OFT development.  
The importance of Vegf signaling in endocardium has recently been shown. 
Deleting the Vegf receptor, Neuropilin 1, in endocardial cells disrupts OFT development 
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with abnormal cushion morphogenesis (Zhou et al., 2012). This finding indicates that 
endocardium is a target cell for Vegf signaling. There are no previous findings 
implicating Vegfa signaling in CNC development. Our data suggest that elevated Vegfa 
inhibits CNC influx into the OFT, however, more experiments are required to 
definitively make this conclusion.  
A mechanism to tightly modulate Vegfa activity in the developing heart 
Previous genetic studies have shown that Vegfa dose must be maintained within 
a narrow window for normal embryonic development. Vegfa heterozygosity, with 
reduced dosage, as well as small gains in Vegfa activity result in defective embryonic 
development. Loss of a single Vegfa allele is embryonic lethal at mid-gestation due to 
impaired angiogenesis and blood-island formation (Ferrara et al., 1996). Moreover, there 
are cardiomyoblast differentiation defects in Vegfa heterozygotes. Haigh et al. found that 
heterozygous inactivation of Vegfa using Collagen2a1-Cre caused embryonic lethality at 
E10.5 with defects in myocardial and endocardial layers of the heart (Haigh et al., 2000). 
A different Vegfa allele, Vegf
lo
, results in a three-fold overexpression of Vegfa during 
development. Heterozygotes for this allele are viable, however, homozygous embryos 
die at E9.0 with dorsal aortae defects and severe abnormalities in yolk sac vasculature 
(Damert et al., 2002).  
Our data indicate that in the OFT, Vegfa activity is concurrently regulated by 
Smad transcriptional repression and post transcriptional repression by miRs. Vegfa has 
been previously reported to be regulated by miRs, including the miR-17 family, in other 
contexts including cultured breast cancer cells and diabetes (Cascio et al., 2010; Long et 
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al., 2010). However, our finding that miR regulation cooperates with Smad mediated 
repression provides new insight into the mechanisms underlying tight Vegfa dosage 
regulation.  
Bmp interacts with Calcineurin-NFAT signaling 
Previous work indicated that NFATc1 mutants have conotruncal valve 
phenotypes similar to Mef2c-cre;Bmp 2,4,7 triple mutant (Y. Bai and J. Martin, in 
preparation).  Moreover, similar to what we have discovered for Bmp-signaling, 
NFATc1 inhibits Vegfa expression in the E9.5 OFT to permit EMT (Chang et al., 2004; 
Stankunas et al., 2010). NFATc1 expression was reduced in the AV cushion 
endocardium of Bmp2 conditional mutant embryos (Ma et al., 2005). There is evidence 
from pulmonary vascular cells that NFAT and Bmp are in a linear genetic pathway 
(Chan et al., 2011). Other intriguing data indicate that NFAT can promote 
chondrogenesis in vitro, a known function for Bmp-signaling (Tomita et al., 2002). More 
work will be required to investigate potential interactions between NFAT-calcineurin 
and Bmp signaling in the developing OFT.  
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Summary 
Congenital heart disease (CHD) is a common and devastating anomaly that 
affects approximately 1% of live births. Defects of the outflow tract make up a large 
percentage of human CHD. We investigated Bmp (Bone morphogenetic protein) 
signaling in outflow tract (OFT) development by conditionally deleting both Bmp4 and 
Bmp7 in second heart field (SHF). SHF Bmp4/7 deficiency resulted in defective 
endothelial to mesenchyme transition (EMT) and reduced cardiac neural crest (CNC) 
ingress with resultant persistent truncus arteriosus (PTA). Using a candidate gene 
approach, we found that vascular endothelial growth factor A (Vegfa) was upregulated in 
the Bmp mutant hearts. To determine if Vefga is a downstream Bmp effector during 
EMT, we examined if Vegfa is transcriptionally regulated by the Bmp receptor-regulated 
Smad. Our findings indicate that Smad directly binds to Vegfa chromatin and represses 
Vegfa transcriptional activity. We also found that Vegfa was a direct target for miR-17-
92 cluster that is also regulated by Bmp signaling in SHF. Deletion of miR-17-92 reveals 
similar phenotypes as loss of Bmp4/7 SHF deletion. To directly address the function of 
Vegfa repression in Bmp mediated EMT, we performed ex vivo explant cultures from 
Bmp4/7 and miR-17-92 mutant hearts. EMT was defective in explants from Bmp4/7 
dCKO (Mef2c-Cre;Bmp4/7
f/f
) and miR-17-92 null. By antagonizing Vegfa activity in 
explants, EMT was rescued in Bmp4/7 dCKO and miR-17-92 null culture. Moreover, 
overexpression of miR-17-92 partially suppressed the EMT defect in Bmp4/7 mutant 
embryos. Together, our study unveils that Vegfa levels in OFT are tightly controlled by 
Smad- and miR-dependent pathways to modulate OFT development (Fig. 10). 
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Figure 10.  Molecular mechanism on Bmp regulation of OFT development.  Bmp 
signals regulate EMT related genes such as Twist1/2, Id1/2, snail1 and slug, to promote 
invasive EMT. In addition, Bmp control vegfa expression by Smad and miR 
mechanisms to regulate non-invasive EMT. All together are important for the normal 
OFT cushion morphogenesis 
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CHAPTER III 
BMP SGINALING DISRUPTION IN SECOND HEART FIELD IMPAIRS AORTA 
DEVELOPMENT AND EARLY ONSET OF AORTA ANEURYSM 
 
Background and Significance 
Marfan syndrome (MFS) is a heritable connective tissue disorder that occurs at 1 
individual per 3000-5000 in the population. It’s first described by Antoine Marfan a 
French pediatrician in 1896 and well known for its classic physical features such as 
pectus excavatum, lens ectopia, arachodactyly, and tall stature. MFS is widely reported 
because of aortic root dilation and dissection, which is the major cause of mortality in 
this population (Jain et al., 2011; Milewicz et al., 2008; Neptune et al., 2003). Lack of 
cure for MFS, the syndrome is treated by preventive medication to slow progression of 
aortic dilation or surgical replacement of the aorta (Groenink et al., 2013; Mirick et al., 
2013).  
Fibrillin-1 (Fbn-1) is one of the genes identified as linked to MFS (Dietz et al., 
1991). Fbn-1 locus encodes a 350-kDa glycoprotein fibrillin-1, which is essential for the 
proper formation of extracellular matrix (ECM). It has a “beads-on-a-string” structure 
when viewed by electron microscope (Dietz and Pyeritz, 1995). Fbn-1 protein is pivotal 
for structural integrity of the microfibrils which provide a scaffold for elastic fibers 
(Yanagisawa and Davis, 2010), and also serves as a reservoir for growth factors such as 
Tgf-β and BMP to modulate their bioactivity (Nistala et al., 2010). Interaction between 
Tgf-ß signaling and Fibrillin-1 has been well described. After it is synthesized, Tgf-β 
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ligand forms homodimer and interact with a latency associated peptide (LAP) to form a 
complex called small latent complex (SLC). SLC is then binds to latent Tgf-β-binding 
protein (LTBP) to form large latent complex (LLC) to be secreted to the ECM. Fbn-1 
protein can bind LLC to control the levels of Tgf-β signal. Mutation in Fbn-1 causes 
malfunction of sequestering Tgf-β by releasing LLC in the ECM, thus results in 
increased activity of Tgf-β ligands (Neptune et al., 2003). Increased level of Tgf- ligands 
in the ECM then causes increased Tgf-β signaling in surrounding cells, detected as 
increased phosphorylation level of the downstream target Smad2 (pSmad2).  
Non-canonical Tgf-β signal pathway is also associated with MFS (Holm et al., 
2011). Activation of Jun N-terminal kinase-1 (JNK-1) is detected in Smad4-deficient 
MFS mice (S4
+/-
, mice harboring a deletion of exon 8 of the Smad4 gene) (Holm et al., 
2011), but a JNK antagonist attenuated aortic growth without retained full Smad4 
expression.  Losartan is a blocker for angiotensin II type I, and it is known to suppress 
the expression of Tgf-β ligands. Treatment of losartan can achieve some rescue by 
reduction of ERK1/2 activation (Holm et al., 2011).  
         Genes encoding smooth muscle actin are associated with MFS. The vascular 
smooth muscle cells (SMCs) are the major cell component of aorta media and functions 
as contract machinery to regulate pulse pressure and blood flow. In addition, SMCs 
function as a mechanistic sensor to monitor the biomechanical force. Alternations of 
SMC proteins including ACTA2 and MYH11 cause aorta aneurysm (Milewicz et al., 
2008), which is caused by activation of SMC repair pathways through activation of 
MMP and renin-angiotensis system.Tgbr2 mutation lead to decreased expression of 
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SMC contractile protein which contribute to the pathogenesis of aneurysm (Inamoto et 
al., 2010). SMC-specific ablation of Tgfbr2 resulted in impaired elastogenesis and 
aneurysm in mice embryos which was prone to dilation and aneurysm (Choudhary et al., 
2009). 
          More recently miR has been studied in relation with ECM and aortic aneurysm. 
miR is a small non-coding RNA molecule (~22 nucleotides) found in plants and animals. 
They can orchestrate gene expression profiles associated with phenotype and disease. 
miR-29, which is a Tgf-β-responsive miR, has been identified to play a important role 
during aortic development and aging. This family (miR-29a/b/c) has been studied to 
target genes that encode ECM proteins including collagen genes such as CoL1A1, 
CoL1A2 and CoL3A1; Fbn-1, and elastin (ELN) (van Rooij et al., 2008).  Reduction of 
miR-29b in the aortic wall can ameliorate abdominal aortic aneurysm (AAA) 
progression in pancreatic elastase (PPE) infusion model in C57BL/6 mice and AngII 
infusion model in Apoe-/- mice (Maegdefessel et al., 2012). However, the increased 
level of miR-29b is not detected in mouse model of TAA (Thoracic aorta aneurysm) and 
human TAA tissue.  
 BMP is a member of Tgf-β superfamily and its signal is transduced through a 
canonical pathway involving phosphorylation of Smad1/5/8 by the ligand-receptor 
complex (Bai et al., 2013). Upon binding with Smad4, pSmad1/5/8-Smad4 complex 
shuttles from cytoplasm to nucleus and function as transcriptional factor, either activator 
or suppressor (Kawabata et al., 1998; Zwijsen et al., 2003). BMP is also associated with 
regulation of miR transcription. miR-17-92 is reported to be a downstream target of 
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BMP signal pathway to regulate OFT development and differentiation (Bai et al., 2013; 
Wang et al., 2010).  
Although little evidence is revealed about the interaction of BMP and Fbn-1, 
studies show that mice deficient in both Fbn-1 and Fbn-2 exhibit PTA, which is found in 
the mice with loss of BMP and Tgf-β signaling. In addition, in the developing autopad, 
Fbn-2 deficient mice show loss of Bmp7 and recapitulate the syndactyly phenotype 
observed in Bmp7 mutant mice (Arteaga-Solis et al., 2001). Like it controls Tgf-β 
activity, Fbn-1 controls the bioactivity of BMP ligands in the ECM during bone 
formation (Nistala et al., 2010). 
         In this study, we found that loss of Bmp4 can exacerbate aortic phenotype 
including aorta aneurysm, collagen disposition and elastic fragmentation in adult. During 
development, BMP directly regulates Fbn-1 associated with regulation of Tgf-β signal 
pathway. Loss of BMP results in smooth muscle cells in the aorta to fail to terminally 
differentiate. Furthermore, miR-17-92 overexpression can compensate the abnormality 
caused by loss of BMP signal, including suppression of sarcomeric actin expression and 
Tgf-β activation. Here we first identified that BMPsignaling plays an important role in 
aorta aneurysm development and shed a light on the underlying molecular mechanism of 
MFS, providing potential treatment targets for the clinical trial.  
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Material and Methods 
Mouse lines  
The Bmp4 flox, miR-17-92 null and miR-17-92
OE 
alleles and Mef2c-Cre lines 
have been previously described (Liu et al., 2004; Ventura et al., 2008; Verzi et al., 2005; 
Xiao et al., 2008). Bmp7 flox mice have been described earlier (See A-1(Bai et al., 
2013)). miR- 17-92 LacZ transgenic mice is previously described (Wang et al., 2013). 
Fbn-1
C1039G/+ 
lines have been previously described (Bai et al., 2013; Judge et al., 2004; 
Liu et al., 2004; Ventura et al., 2008; Verzi et al., 2005; Xiao et al., 2008).  
β-galactosidase staining, histology and imaging 
Embryos were fixed overnight in buffered formalin, dehydrated through graded 
ethanol, and paraffin embedded. Sections were cut at 7 µm and stained with H&E. 
detection of LacZ expression on whole embryos was performed as previously described 
(Lu et al., 1999).  
Adult hearts were dissected from animal and fixed in 4% paraformaldehyde 
(PFA) overnight at 4˚C. Samples are transfer to 70% ethonal for dissection and storage, 
then dehydrated through graded ethanol, paraffin embedded, and sectioned. Sections 
were stained for standard stains including Russell-Movat pentachrome stain, or 
Masson’s Trichrome staining.  
Whole mount image were taken by Zeiss Stereomicroscope. Slides images were 
taken by Nikon microscope. 
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Immunofluorescence staining 
Immunofluorescence analysis were performed on either frozen or paraffin 
sections. For frozen section, embryos were embedded in OCT, snap freezed and 
sectioned to 8 µm on Superfrost/Plus Slides (Fisher Scientific, Pittsburgh, PA). After air 
dry for 10 mins, slides were fixed in cold acetone for 10 mins, followed by 4 mins 
rehydration in PBS at room temperature.  
For paraffin section, embryos were fixed in 4% PFA, dehydrated, embedded in 
paraffin and cut to 7 µm sections. The antigens were retrieved by incubating in 10 mM 
citrate buffer for 20 mins at 100°C or as suggested by manufacturers of the antibodies.  
Fbn-1 antibody is courtesy of Dr. Lynn Sakai (Oregon Health & Science 
University). The source and concentration of primary antibodies are α-SMA-Cyan3 
(1:100; Sigma-Aldrich), anti-MF20 (1:200; Developmental Studies Hybridoma Bank), 
anti-Isl1 (1:200; Developmental Studies Hybridoma Bank), p-Smad2 (1:200; Cell 
signaling #9510). HRP-conjugated secondary antibody (Bio-Rad Co., Hercules, CA) was 
used and visualized using TSA
TM
 plus Fluorescence Systems from PerkinElmer (Boston, 
MA), or Alex Fluor○R488 Goat anti-rabbit IgG(H+L) (1:500; Invitrogen A-11008) was 
used. Nuclei were stained with Dapi (invitrogen). Images were taken by Zeiss LSM 510 
meta confocal microscope.  
In vivo chromatin immunoprecipitation and ChIP-PCR  
Approximately 40 aorta of E14.5 wild type mouse embryos were dissected and 
followed by the chromatin immunoprecipitation (ChIP) analysis. Soluble chromatin was 
prepared after formaldehyde crosslinking and sonication by Bioruptor. Smad1/5/8 
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antibody (sc-6031 X, Santa Cruz) was used to immunoprecipitate protein-bound DNA 
fragments.  Rabit IgG was used as control.  Primers designed for irrelevant chromatin 
sequence to Smad were used as a negative control. SYBR Green was used for ChIP-
qPCR and results were analyzed by fold change method (Invitrogen). Primer sequences 
are available in supplementary material Table S1. 
Transthoracic echocardiography  
Transthoracic echocardiography was performed on 2, 3. 10 month old Mef2c-
Cre;Bmp4
f/+
;Fbn-1
C1039G/+ 
and Control male mice (Bmp4
f/+
).. Mice were anesthetized by 
1.5% isoflurane inhalation and placed on a heated platform (37 °C) with integrated 
physiological monitoring capabilities. Two-dimensional B-mode imaging was recorded 
using VisualSonics 770 system (Toronto, Canada) with a 30 MHz scanhead (RMV707B) 
to capture long axis projection with guided M-Mode and PW Doppler recorded. The 
average reading for each echocardiographic parameter was recorded from at least 3 
distinct frames from each individual of the 2 experimental groups. Statistical 
significance was determined using Student's t-test (p < 0.05). 
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Results 
BMP4 haploinsufficiency aggravates aorta aneurysm in Fbn-1
C1039G/+
 
To understand role of BMP in adult mice, we first examined Bmp4 expression 
using Bmp4
LacZneo 
mice (Bai et al., 2013; Bonilla-Claudio et al., 2012; Lawson et al., 
1999; Selever et al., 2004; Wang et al., 2010).  Bmp4 was consistently expressed in the 
coronary sinus, aorta, pulmonary artery and coronal vessels (A-4, A,B). Sections showed 
that Bmp4 was expressed in endothelium, media and smooth muscle of the aortic vessel, 
atrium-ventricular valves (Fig. 12A), but no signal was detected in the aorta valve (data 
not shown). Expression of Bmp4 in adult suggests it may have function in adult. 
 
Figure 11. Study strategy for Bmp function assay on aorta. To study the roles of 
Bmp on aorta maintenance,  Mef2c-Cre;Bmp4
f/+
 is crossed with mice carry Fbn1
C1039G/+
,  
progeny with different genotype are examined as indicated.  
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To determine the role of BMP signaling in Marfan syndrome, we examined the 
roles of BMP in adult aorta. Since homozygous mutant of Bmp4 does not survive till 
adulthood, we analyzed combined heterozygous of Bmp4 and Fbn-1
C1039G/+
(Mef2c-
Cre;Bmp4
f/+
;Fbn-1
C1039G/+
, Bmp4;Fbn-1 dHet for short, Fig. 11).
 
Mef2c-Cre, which 
delete genes in the lineage contributes to outflow tract, was used for our study. To 
examine aorta aneurysm, we measured diameter of the aorta root visualized by 
echocardiography analysis at 2, 3 and 10 month-old mice. Bmp4;Fbn-1 dHet shows 
more severe aortic aneurysm than Fbn-1
C1039G/+ 
mice (Fig.12B), with significant increase 
of aorta dimension as early as 2 month old (Fig. 12C).  
At 10 months, Bmp4;Fbn-1 dHet mutants exhibit aorta dilation. We found severe 
aneurysm in Bmp4;Fbn-1 dHet mutants in gross level at 10 months, with different 
penetration. Histological analysis reveals the aorta morphology of 10 month-old mice.  
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Figure 12. Haploinsufficiency of Bmp exacerbates aorta aneurysm in Fbn-1
C1039G+/-
 
mice. Adult animals of control (Bmp4
f/+
), BMP4 het (Mef2c-Cre;Bmp4
f/+
), Fbn het 
(Fbn-1
C1039G/+
), and BMP4; Fbn dHet (Mef2c-Cre;Bmp4
f/+
;Fbn-1
C1039G/+
) were analyzed 
for aorta aneurysm. A: Expression of Bmp4 examined by LacZ staining. scale bar =50 
μm. B: Echocardiography analysis on 2, 3, 10 month-old adult mice. Distance between 
yellow dotted line were measured (arrow). a: atrium, ao: aorta, rv: right ventricle. C: 
Aorta dimension of 2 and 3 month old mice. Aorta dimension is measured by Image J 
software from echoed mice, each mice were measured at 3 times and average is used for 
statistical analysis. p-value is analyzed by t-test (two tailed). * P<0.05. D-O: Histological 
analysis on 10 months old aorta of the control (D, H, L), BMP4 het (E, I, M), Fbn-1 het 
(F, J, N), and double het (G, K, O) mice. D-G: H&E staining. H-K: Trichrome staining. 
Collagen is stained blue, nuclei is stained black, muscle, cytoplasm and keratin is stained 
red. L-O: Movat staining. Nuclei and elastic fibres are stained black, collagen fibres are 
stained yellow, mucin is stained blue, fibrin is stained bright red, and muscle is stained 
red.  Scale bar (green)=50 μm (D-O). 
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H&E staining showed that Bmp4;Fbn-1 dHet mice had thicken media and 
abnormal smooth muscle cells with elongated cell shape in the aorta (Fig.12D-G). We 
found increased collagen deposition indicated in blue staining in Fbn-1
C1039G/+ 
 compare 
to control, and more collagen deposition was detected in Bmp4;Fbn-1 dHet visualized by 
trichrome staining (Fig.12H-K). In addition, we found disorganized and fragmented 
elastin fibers in Fbn-1
C1039G 
and the level of defect is more sever in Bmp4;Fbn-1 dHet
/+ 
(Fig.12L-O). Mef2c-cre;Bmp4
f/+
 mice also showed mild aortic phenotype compared to 
control (Fig.12D,H,L). Surprisingly, we found disrupted assembling of α-SMC in 
Mef2c-cre;Bmp4
f/+
 , as well as in Fbn-1
C1039G/+ 
 and  Bmp4;Fbn-1 dHet (A-5). These 
results indicate that mice with BMP and Fbn-1 mutation were more prone to develop 
dilated aorta root even at young stage, with worse pathology aorta with aging which is 
likely to contribute to aorta aneurysm and rupture.  
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Figure 13. Bmp2/4/7 ablation results in OFT abnormality. A-D: Histological analysis 
on control (Bmp2/4/7
f/f
) and Bmp2/4/7 CKO (Mef2c-Cre;Bmp2/4/7
f/f
). E14.5 embryos 
were collected, sectioned, and stained for H&E for histological analysis. Panels B and D 
are zoomed-in images of panels A and C, respectively. Arrows show disorganized cells 
in the OFT. la: left atrium; ra: right atrium; ao: aorta; av: aorta vavle; pta: persistent 
truncus asteriosus. Scale bar (white)=100 μm; Scale bar (red)=500 μm. 
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Loss of BMP results in disorganized SMC in OFT  
Our results show that aorta dilation occurs at very early age of Bmp4;Fbn-1 dHet, 
indicating Bmp4 regulates aorta formation in early stages or during development. 
Likewise in people, some patients with MFS develop severe aorta aneurysm in early 
childhood, indicating the disease is due to developmental defects. Thus, we determined 
the role of BMP in embryonic mouse model. To begin understating the roles of BMP in 
aorta, we examined its expression pattern during developmental stage. At E14.5, Bmp4 
was expressed in aorta, pulmonary artery and coronary sinus (A-4, F,G).   In contrast, 
Bmp2 was not detected at aorta at E14.5 (A-4, I,J) and adult mice (A-4, C,D), although 
Bmp2 was expressed in the OFT at early embryonic stage (Ma et al., 2005). However, 
Bmp2 was expressed in pulmonary artery throughout development (A-4, C,H).  Whole 
mount hybridization demonstrated that Bmp7 was expressed in the whole heart loop 
during developmental stage (Bai et al., 2013). Thus, all three ligands potentially regulate 
aorta development.  
 Because of function redundancy of BMP ligands and overlapping expression of 
Bmp2, Bmp4, Bmp7 in the OFT during development, we crossed mice carrying Mef2c-
Cre and Bmp2/4/7 flox allele with mice carrying Bmp2/4/7 flox/flox allele. Bmp2/4/7 
CKO (Mef2c-Cre;Bmp2/4/7
f/f
) exhibited PTA phenotype (Fig.13C), consistent with 
previous studies (Bai et al., 2013). The single truncus showed aberrant morphology, 
including disorganization of the cells, dilated OFT root and thickened vessel wall 
(Fig.13C, D). Similar phenotype was observed in other combined ablation of BMP 
ligands (A-6, A-H). In addition, Bmp2/4/7 CKO formed no valve, had small right 
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ventricle and ventricular septum defect (VSD) (data not shown).  These data suggested 
that BMP ligands are essential for the morphogenesis of OFT, in addition to the 
septation of aorta and pulmonary artery (Bai et al., 2013; Ma et al., 2005).  
 
Figure 14. Bmp positively regulate Fbn-1. A: Expression of Fbn1 was examined by 
immunohisctemistry in the E14.5 hearts of control and Bmp2/4/7 CKO embryos.  
Arrows in right panel show decrease in Fbn-1 expression. Scale bar (white)=100 μm; la: 
left atrium; ao: aorta; av: aorta vavle; pta: persistent truncus asteriosus. B: qRT-PCR 
analysis of aorta tissue of control and Bmp2/4/7 CKO. p-value is analyzed by t-test (two 
tailed). * P<0.001. (control n=8, mutant n=4). Error bars represent S.E.M. C: ChIP-PCR 
analysis on Fbn-1 5’ upstream regulatory regions. ChIP-PCR on aorta from wild type 
mice shows the enrichment of flag in regions we interested in. Smad1/5/8 antibody is 
used to pull down Smad-binding chromatin and after reverse crosslink, DNA is purified 
to perform PCR. D: Graph shows calculation of fold enrichment of input by ChIP-qPCR. 
Experiments are run in triplicate. We use ChIP DNA and performed quantitative PCR. 
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Fbn-1 is positively regulated by BMP signaling 
Since Fbn-1 is linked to Marfan syndrome and required for OFT elasticity, we 
determined the level of Fbn-1 expression in mutant embryos. Fbn-1 expression was 
dramatically decreased and restricted to the inner layer of OFT root, comparing to the 
aorta of control embryos (Fig.14A). It was notable that in the area that has fibrillin, the 
fibrils do not follow the lumen in clear rings in the mutants. qRT-PCR illustrated that 
mRNA level of Fbn-1 was dramatically decreased in Bmp2/4/7 CKO (Fig. 14B). 
Surprisingly, we did not detect abnormality of Fbn-1 in the ablation of Bmp4 and Bmp7 
(A-7), which suggests that either Bmp2 regulates Fbn-1 expression mainly or the amount 
of Bmp signal is critical for the maintenance of Fbn-1 during development.  
To determine if Fbn-1 transcription is directly regulated by BMP pathway, we 
analyzed Fbn-1 upstream, and found several putative Smad binding elements (A-8). To 
validate these binding sites, primers flanking to the sites were designed to detect PCR 
product on ChIP sample. In the Smad1/5/8 antibody pull-down sample, all three set of 
primers gave rise to enriched PCR products (Fig. 8C), which suggested direct physical 
interaction between Smad and chromatin, with 45%, 58%, 42% of fold enrichment 
correspondingly (Fig. 14D).   
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Fbn-1 plays a role in Tgf-β sequestration to control bioavailability of the ligands. 
Thus, we examined the levels of intracellular Tgf-β signaling by determining pSmad2.  
pSmad2 positive cells was expanded to OFT in Bmp2/4/7 CKO embryos, showing Tgf-β 
signal pathway was activated by loss of BMP (Fig.15A-D). 
 
Figure 15. Activation of Tgf-β signal in the absence of Bmp2/4/7. A-D: 
Immunohistochemical analysis on pSmad2 in the hearts from control (A, B) and 
Bmp2/4/7 CKO (C, D) at E14.5. Panes B and D are zoomed in images of A and C, 
respectively. la: left atrium; ra: right atrium; ao: aorta; av: aorta vavle; rv: right ventricle; 
lv: left ventricle; pta: persistent truncus asteriosus. Scale bar (white)=100 μm; Scale bar 
(red)=50 μm. 
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BMP regulates SMC differentiation of the OFT 
To further understand the cause of disorganization of the cells in OFT, we 
examined cell types in the OFT. Majority of the cells in OFT are SMC, however during 
early development, OFT also expresses cardiac muscle markers around E9.5-E10.5 
(Wang et al., 2010). To characterize the OFT cells, we determined the expression of 
cardiac marker, sarcomeric myosin (MF-20) and smooth muscle marker, alpha-smooth 
muscle actin (α-SMA) at E14.5. MF-20 was not detected in the control aorta, while it 
was detected within the mutant OFT. Double staining demonstrated the overlapping 
expression of MF-20 and α-SMA in CKO OFT (Fig.16A-D).  
SHF progenitor marker Isl-1 is reported to control the OFT differentiation at 
early embryonic stage (Wang et al., 2010), and timely silence of Isl-1 is required for 
proper development of OFT. To determine if OFT cells in Bmp2/4/7 CKO are 
progenitor cells, we examined Isl-1 expression. Immunochemistry staining demonstrated 
that Isl-1 positive cells were persistently existed in BMP mutant, which is not detectable 
at E14.5 in control (Fig.16E-H). Quantification indicates that Isl-1 positive cells are 
significant increased in the absence of Bmp2/4/7 (Fig.16I). The results show that the 
OFT of Bmp2/4/7 CKO embryos is in multi-potent progenitor stage expressing both 
cardiac and smooth muscle markers, suggesting that BMP regulates SMC differentiation.  
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Figure 16. Bmp2/4/7 ablation results in disruption of smooth muscle cell fate. 
Immunohistochemical analysis is performed on E14.5 hearts of control (A, B, E, F) and 
Bmp2/4/7 CKO (C, D, G, H). A-D: Immunohistochemical analysis of MF20 (green) and 
α-SMA (red) on the control (Bmp2/4/7f/f) and Bmp2/4/7 CKO OFT. Nuclei are stained 
with DAPI (blue). Panels B and D are zoomed-in images of B and D, respectively. 
Arrows in panel D show double staining of MF20 and α-SMA. Scale bar (white)=100 
μm; Scale bar (red)=50 μm.E-H: Immunohistochemical analysis on Isl-1 (green). Nuclei 
are stained with DAPI (red). Panels F and H are zoomed-in images of E and G, 
respectively. Arrows in panel H shows Isl-1 positive nuclei. la: left atrium; ra: right 
atrium; ao: aorta; av: aorta vavle; rv: right ventricle; lv: left ventricle; pta: persistent 
truncus asteriosus. Scale bar (white)=100 μm; Scale bar (purple)=20 μm. 
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Figure 17. miR-17-92 overexpression partially restores the phenotype. A-F: 
Immunohistochemical analysis on control (A, D), BMP4/7 CKO (B, E), and BMP4/7 
CKO; mir-17-92OE (C, F) hearts from E14.5 embryos. A-C: Immunohistochemical 
analysis on MF20 and α-SMA on control (Bmp4/7f/f), Bmp4/7 CKO and miR-17-92 OE 
embyos at E14.5. Arrows in panel B show double positive cells for MF20 and α-SMA 
expanded in the OFT.  and panel C show this expansion is absent in miR-17-92 OE, as 
shown by arrowhead.) D-F: Immunohistochemical analysis on P-Smad2 on embryos at 
E14.5. Arrows in panel E show pSmad2 positive cells in OFT and valve; Arrowheads in 
panel F show the decreased pSmad2 positive cells in OFT and valveScale bar 
(white)=100 μm. Scale bar (red)=50 μm. G: qRT-PCR of Smad4 and Tgfbr2 in Bmp4/7 
mutants, p-value is analyzed by t-test (two tailed). * P<0.05. (control n=4, Bmp4/7 
dCKO n=4, miR OE n=4). Error bars represent S.E.M. 
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MiR-17-92 overexpression can suppress the OFT defects in BMP mutants 
miR-17-92 is a downstream target of BMP pathway and its overexpression can 
partial rescue loss of BMP signaling in myocardium development and OFT septation 
(Bai et al., 2013; Wang et al., 2010). Thus, we determined if overexpression of miR-17-
92 can rescue the aortic aneurysm caused by loss of BMP in OFT. Here we used Bmp4/7 
dCKO (Mef2c-Cre;Bmp4/7
f/f
) instead of Bmp2/4/7 CKO since Bmp4/7 CKO show 
similar phenotype to that of Bmp2/4/7.   
Bmp4/7 dCKO showed thickening and disorganized OFT similar to Bmp2/4/7 
CKO (A-6). Overexpressinon of miR-17-92 in Bmp4/7 dCKO background (Mef2c-
Cre;Bmp4/7
f
/f;miR-17-92
OE/+
) exhibited the truncus with normal width and cell 
morphology (A-6), indicating the defects of OFT in Bmp4/7 CKO was rescued by miR-
17-92 overexpression. To determine if SMC differentiation is rescued, we performed 
immunostaining of MF20 and α-SMA. Expression pattern of MF20 and α-SMA in miR-
17-92 OE was comparable to control, showing that overexpressing miR-17-92 does not 
alter SMC differentition. Expression of both MF-20 and α-SMA were detected in OFT 
of Mef2c-Cre;Bmp4/7
f
/
f
;miR-17-92
OE/+
, but expansion of MF-20 is rescued compare to 
Bmp2/4/7 CKO (Fig.17A-C), indicating SMC differentiation is partially rescued by 
miR-17-92. Level of pSmad2 was decreased compare to Bmp4/7 dCKO by miR-17-92 
overexpression in BMP4/7 background (Fig.17D-F). Smad4 and Tgfbr2 mRNA levels 
are significant restored by overexpression of miR-17-92 compared to Bmp4/7 dCKO 
(Fig.17G). In addition, overexpression of miR-17-92 repressed Isl-1 expression to some 
extent in BMP4/7 background (A-9, D-F, G-I). All these data indicate that 
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overexpression of miR-17-92 can rescue the defects in cell determination and 
maintaining its cell fate caused by absence of BMP signals. 
 
Figure 18. Working model of  Bmp regulation in Aorta aneurysm. Bmp regulate 
expression of Fbn-1 and SMC differentiation through Smad.  Fbn-1 controls Tgf-β signal 
in normal condition. miR-17-92 plays important roles in control Tgf-b signal and Isl-1 
silencing. In addition, non-canonical Tgf-b signal pathway, such as MAPK, p38, ERK, 
mir-29b are also involved in the contribution of aorta aneurysm based on recent studies.  
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Discussion 
In this manuscript, we showed that BMP signals is involved in aortic aneurysm 
during development and in the adult. BMP pathway regulates expression of Fbn-1 
directly through Smad and suppress Tgf-β signaling. BMP pathway also directs SMC 
differentiation in the aorta. Furthermore, we showed that miR-17-92 can partially rescue 
loss of BMP for SMC differentiation and suppression of Tgf-β signaling. Taken together, 
we propose the model of BMP regulation in Fig. 18. 
Homostasis of TGF-β signal and MFS  
Examination of plasma sample show that circulating total Tgf-β1 concentrations 
are significant increased in MFS patients without cardiovascular drug treatment 
compared to control individual, while MFS patients treated with losartan or β-blocker 
show dramatically lower Tgf-β1 concentration compared with untreated patients (Matt et 
al., 2009). Mutation in Tgf-β is identified in some of Marfan patients (Neptune et al., 
2003). Although the majority mutation of Tgf-β are indicated to affect the proper 
function of these proteins, diseased aortic tissue from Marfan Syndrome patients show 
increased p-Smad2 in aortic SMCs (Attias et al., 2009; Boileau et al., 2012; Loeys et al., 
2006), consist with the phenotype we found in BMP mouse model. Surprisingly, 
decreased Tgf-β  signal also exacerbates aorta aneurysm in mouse model. Recent study 
onTgfbr2 inactivation in postnatal SMCs shows rapid aorta thickening, dilation and 
dissection (Li et al., 2014).it suggests that basal TGF-β signal is important to maintain 
aortic wall homeostasis and normal function of aortic smooth muscle. MAPK and p38 
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signal pathway are reported to contribute to aorta malfunction in Tgf-β disrupted mouse 
model.  
Unlike Tgf-β, BMP has not been reported to be genetically associated with 
Marfan syndrome although it is a member of Tgf-β superfamily. However, regulation of 
BMP and Tgf-β bioactivity by Fbn-1 is proposed in bone formation. There are possible 
several reasons why the role of BMP in Marfan syndrome is poor studied. First, BMP 
ligands are functional redundant that single mutation is not enough to exhibit phenotype. 
Second, compound mutations result in embryonic lethal that make it impossible to study 
afterbirth phenotype. Bmp2/4/7 triple CKO die around E16.5-E18.5. Bmp4/7 and 
Bmp2/4 dCKO is also embryonic lethal (Bai et al., 2013; Wang et al., 2010). Third, early 
perturbations might result in later-onset phenotype in adulthood, but it’s hard to trace 
back. In our study, we found that Bmp4;Fbn-1 dHet developed severer aorta aneurysm 
than Fbn-1
C1039G/+ 
by itself. Although Bmp4 heterozygous is viable due to compensation 
of other BMPligands, the gross morphology of aorta is abnormal comparing to its 
littermates. Haploinsufficent of Bmp4 makes the adult mice predisposed to severe 
aneurysm.  It is possible that in aorta aneurysm patients, some of this population might 
have disturbed BMP signals during the embryonic stage. Activation of Tgf-β signals also 
bring up a possibility that maybe Losartan treatment can help the phenotype observed in 
BMP mutant. Further experiments are needed to address this hypothesis.  
BMP-YAP signal pathway to regulate SMC homeostasis 
Previous studies show that Yap can form complex with linker-phosphorylated 
Smad (Alarcon et al., 2009). Phosphorylated Yap is located in cytoplasm indicated the 
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activation of Hippo pathway (Heallen et al., 2013; Heallen et al., 2011). In our 
preliminary data (not shown), we found that nucleus Yap is significant increased on 
stiffer matrix compared to soft matrix, which suggest that Yap and Smad can regulate 
genes that are important for SMC homeostasis in the context of high mechanical stress 
matrix. In the MFS patient, aorta stiffness is increased, SMC is fragmented and aorta is 
easier to rupture. In our Bmp mutant mouse model, the deletion of Bmps results in the 
downregulation of nucleus Smad1/5/8 in Smooth Muscle cells, which in turn will not be 
sufficient to form complex with Yap to regulate their downstream genes in the context of 
stiffer SMC.  However, it is still not clear if it is a cause or effect. Besides, the balance 
between activation of pSmad2 and inactivation of Smad1/5/8 is still not well understood 
with regard to the cooperative effect with Yap.  More researches are needed to be done 
to test this hypothesis.  Moreover, it is also interesting to explore if Fbn is moderated by 
Smad-Yap complex.   
MicroRNA-mediated SMC differentiation by BMP and MFS 
Studies in MFS illustrated genes involved in comtractile SMCs are responsible 
for aortic diseases. MYH11, ACTA2 mutations in human result in aortic aneurysm and 
dissection due to perturbed contractile apparatus (Milewicz et al., 2008). Interestingly, 
SMCs are not terminally differentiated even in adult. They retain phenotypic plasticity 
and can de-differentiated in response to vascular injury or environmental cues including 
growth factors/inhibitors, mechanical influences and ect. 
          In our previous study, we found that miR participated in OFT smooth muscle 
differentiation (Wang et al., 2010). However, not so many microRNAs are found to be 
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involved in Marfan syndrome. Increased miR-29b is detected in early aneurysm 
development of MFS by regulating aortic wall apoptosis and extracelluar matrix 
abnormalities. In our study, we found that miR-17-92 can partially restore Bmp4/7 
dCKO phenotype. However, due to the Cre activity and limited increased fold of miR, it 
is still not clear to what extent and at what amount that miR-17-92 can help with Marfan 
syndrome. Interestingly, we also find a miR-17-92 binding site in 3’UTR of Fbn-1, 
which means Fbn-1 is a potential target of miR-17-92, the feed back loop makes the 
rescue event even more complicated. The other question we are trying to address here is 
that whether activation of Isl-1, a downstream target of miR-17-92, is the cause or the 
effect in our mouse model. There are two possibilities, 1) lack of inhibition-the cause. 
BMP positively regulate miR-17-92 transcription which is responsible for the inhibition 
of Isl-1 at certain time window. Deficiency of BMP results in decreased miR-17-92 and 
later activation of Isl-1 expression which results in the multi-potent cell state of “smooth 
muscle cells”, along with the gross morphology change; 2) lack of differentiation-the 
effect. Ectopic expression of MF20 contributes to the de-differentiation of smooth 
muscle cells, and this de-differentiation triggers smooth muscle cell repair system to 
activate Isl-1 expression. In the miR-17-92 overexpression mouse model, we found that 
Isl-1 is decreased and ectopic MF20 expression is diminished. It indicates that MF20 is 
inhibited by miR-17-92 by suppression of Isl-1, in other words, activated Isl-1 facilitates 
MF20 expression. Although we did not detect difference of α-SMA protein expression in 
either mutants, but can’t rule out any subtle change of cell structure and architecture, 
considering the extreme morphology change in Bmp2/4/7 CKO. These data suggest that 
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therapeutic manipulation of miR-17-92 and its target genes holds promise for ameliorate 
TAA disease progression and protecting from dissection.  
BMP deficiency, hypoxia and inflammation in aorta aneurysm 
Great vessels are maintained by blood perfushion in the lumen as well as Vasa 
Vasorum (VV) through unclear mechanism. VV is especially important for the normal 
function of adventitia and media of great vessels. Hypoxia induces abnormality of VV, 
including the hyperplasia of smooth muscle, and enlargement and expansion of VV. In 
our mouse model, we found that smooth muscle, which called media when developed, of 
BMP mutants are impressively messed up, with very fat and loosen morphology and 
increased VV in the adventitia layer (data not shown). Intriguingly, BMP mutants have 
VSD and valve defect, which might be the cause of hypoxia of vessels. Therefore, 
whether the disturbance of VV is the cause of weaken smooth muscle layer or the result 
of VSD phenotype is still need to be addressed in the future work. Weakened smooth 
muscle is responsible for the rupture of aorta aneurysm. The concept that hypoxia can 
cause inflammation has gained widely acceptance. Most aneurysm patients have 
upregulated proteolytic pathways within the medial layer of the arterial wall. MMP2 and 
MMP9  activities are increased in aneurysm formation, as well as HIF-1α, which is 
considered to accelerate MMP production from macrophages (Tanaka et al., 2013). It is 
believed that the abnormal processing of Fbn-1 by SMCs can trigger the detachment of 
vascular SMCs from extracellular matrix, which result in the MMP upregulation. 
Therefore, the matrix disruption and elastin fragmentation cause SMCs apoptosis and 
abnormality of the media layer, which worsen the aorta structure (Fedak et al., 2003). 
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Summary 
Marfan syndrome (MFS) is a disease which occurs 1 in 5000 people, and its 
patients have complex symptoms found in the heart, blood vessels, bones and eyes. 
Aortic aneurysm of Marfan syndrome patients is the most risk that results in sudden 
death and mutation in Fibrillin-1 (Fbn-1) has been linked to its cause. However, 
mutation in other genes has been associated with Marfan syndrome. Here, we 
determined that the roles of BMP signaling in aortic aneurysm. Since knockout animals 
of BMP ligands do not survive till adulthood, we analyzed Fbn
C1039G/+
; Mef2c-
Cre;Bmp4
f/+
 double heterozygous mice to investigate the interaction between Fbn-1 and 
BMP signal pathway. Adult mice heterozygous for both Bmp4 and Fbn-1 developed 
dilated aorta root earlier than Fbn
C1039G/+
, which indicates that decreased level of Bmp4 
aggravates aorta aneurysm in Fbn mutant background. To further characterize the roles 
of BMP in OFT development, we analyzed the embryos lacking BMP ligands. Bmp2/4/7 
triple CKO (Mef2c-Cre;Bmp2/4/7
f/f
) exhibit disorganization in tuncus during 
development. Both Fbn-1 mRNA and its protein level are decreased in the absence of 
Bmp2/4/7. Bioinformatic analysis and ChIP-PCR suggest that Smad binds to Fbn-1 
chromatin, indicating that Fbn-1 is directly regulated by BMP signal. Similar to Fbn-1 
mutant, pSmad2 is activated in the OFT of Bmp2/4/7 CKO, further supporting that BMP 
signal is upstream of Fbn-1. Characterization of the cells in mutant truncus revealed that 
they are multi-potent cells expressing both sarcomeric myosin and α-smooth muscle 
actin and expressing Isl-1, the cardiac progenitor factor. Our study suggests that BMP 
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signal is involved in Marfan syndrome by regulating aorta smooth muscle differentiation 
and modifying the pathway can treat the disease. 
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CHAPTER IV 
CONCLUSION 
Studies on Bmp during development stage reveal that Bmps are not only the 
major player for dorsal-ventral axis specification, but also important for organ formation 
and differentiation.  Our studies on developing heart suggest that Bmps are critical for 
cardiogenesis. Disturbance of Bmp signals results in the malformation of heart tube and 
subsequent heart diseases. One of the steps in heart development is EMT, which is the 
pivotal step that controlled by Bmp signals during specific region and certain 
development stage, spatially and temporally. Our studies show defect of EMT in Bmp 
mutant eventually causes septum defect, valve abnormality and AP separation. Vegfa as 
a downstream target of Bmp signal pathway is tightly controlled by Smad- and miR-
dependent mechanism (Fig. 19). Suppression of Vegfa is required for the non-invasive 
EMT of OFT at E10.5, Twist1/2, snail, slug and Id1/2 are important for the invasive 
EMT. Disruption of the EMT process will result in the absence of cushion mesenchyme 
in the OFT and subsequent defect.  
Haploinsufficiency of Bmp4 does not show obvious developmental defect, but 
this small change in embryonic stage makes adult mice more predisposed to aorta 
dilation and rupture, which indicates the early onset of heart disease due to the minor 
disturbance occurred on embryogenesis. Our studies showed that Bmp2, -4, -7 are 
critical for EMT process and smooth muscle differentiation and maintenance during 
development, which may be important for the mechanic stress sense of the great vessels 
of heart.  Inhibition of Isl-1 by miR-17-92 is essential for the proper differentiation of 
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smooth muscle cells. Activation of pSmad2 by either canonical or noncanonical Tgf-β 
signal pathway contribute to the aorta aneurysm (Fig. 19). Disturbance of Bmp signals 
makes the mice susceptible to aorta dialation.  
We showed that miRNAs are involved in some of the BMP pathways. miRNAs 
has been and will be a direction for treatment of congenital heart disease. To explore 
mechanism behinds miRNAs and signal pathway network, more examination is needed 
to test the effect of miRNA on signal pathway as well as the side effects. However, it 
still sheds a light on the new therapy on congenital heart disease, and it will be more 
interesting to understand if the correction of signal pathway activity in adult stage can 
rescue the phenotype caused by embryonic stage. 
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Figure 19. Working model of Bmp regulation in OFT and aorta maintenance. Bmp 
signals regulate its target gens by Smad- or mR-dependent mechanism.  
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APPENDIX 
 
A-1: Targeting scheme for the inactivation of Bmp7. A: Targeting Strategy for Bmp7 
ablation. B: Southern blot analysis of Bmp7flox allele. C: qRT-PCR analysis of Bmp7 in 
wild type and knockout samples. D: quantification of Bmp7 mRNA level. 
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A-2: Oligos used for gene amplification, ChIP-PCR and qRT-PCR 
Primer Sense (5’-3’) Antisense (5’-3’) 
VEGFA-
promoter 
AGGGTACCAGGGGACAGAGCCACA ACCTCGAGCACGATTTAAGAGGGG 
VEGFA-
3’UTR 
GTACTAGTGCCAGGCTGCAGGAAGGA
GCCTCCCTCAGGGTTT 
GGACGCGTTTTGAGATCAGAATTCAATTCTT
TAATACAAA 
s1-mut 
CTGGCCTACCTACCTTTCTGAGGTTTA
GGGTAGGTTTGAATCACC 
GGTGATTCAAACCTACCCTAAACCTCAGAAA
GGTAGGTAGGCCAG 
SBE1-mut 
CAGGAGGAACAAGGGCCTCTGAATTC
CCAGCTGTCTCTCCTTCAG 
GAAGGAGAGACAGCTGGGAATTCAGAGGCC
CTTGTTCCTC 
SBE2-mut 
CTCCTTCAGGGCTCTGCCTCGAGACAC
AGTGCATACGTGG 
CCACGTATGCACTGTGTCTCGAGGCAGAGCC
CTGAAGGAG 
SBE3-mut 
CGTGAACTTGGGCGAGCCGAAATTTC
GTGAGGGAGGACGCGTGTG 
CACACGCGTCCTCCCTCACGAAATTTCGGCT
CGCCCAAGTTCACG 
3’UTR-mut 
GGAGACTCTTCGAGGACTCGAGCGGG
TCCGGAGGGCGAGACTCCGG 
GGAGACTCTTCGAGGACTCGAGCGGGTCCG
GAGGGCGAGACTCCGG 
Site1-ChIP TGGGAGGACAGAGTACACCCCTGA CAGAGGCCCTTGTTCCTCCTGA 
Site2-ChIP GGCACCCTGGCTTCAGTTCCC TGCGTGTTTGACCTCGGAAGC 
Site3-ChIP CCCCTTTCCAAGACCCGTGCC ACCCCTGGCTTTCTCCCCCA 
Id1 CCGCTCAGCACCCTGAACGG CCCCTGGGGAACCGAGAGCA  
Id2 TCCAGGACGCCGCTGACCA CAACGTGTTCTCCTGGTGAAATGGC 
Slug GCACTGTGATGCCCAGTCTA CAGTGAGGGCAAGAGAAAGG 
Snai1 AAACCCACTCGGATGTGAAG GAAGGAGTCCTGGCAGTGAG 
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A-3: Expression of Bmp2/4/7 in the heart at E9.5 and E10.5. (A-F): Bmp4 is 
expressed in second heart field (SHF), out-flow tract (OFT), in-flow tract (IFT) and right 
ventricle (rv) at E9.5. Sections reveal that Bmp4 is exclusively expressed in myocadium 
but not in endocardium or cushion mesenchyme of the OFT.  (G-L): Bmp2 is expressed 
in the OFT and AV cushion in both E9.5 and E10.5 embryos. Its expression in the OFT 
is limited. (M-R): In situ hybridization of Bmp7 probe shows that Bmp7 is broadly 
expressed in the entire heart tube. At E10.5, Bmp4 expression is restricted to the 
myocardium of OFT; Bmp7 expression is similar to its E9.5. Scale bar=100 µm. 
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A-4: Bmp4 is expressed in pulmonary and aorta during development. (A-E): Bmp4 
and Bmp2 expression pattern at E14.5. Hearts from Bmp4
LacZneo/+
 and Bmp2
LacZneo/+
 
embryos are harvest at E14.5 and performed LacZ staining. Whole mount images are 
taken afterwards. Scale bar (red)=500μm. (F-I): Hearts from Bmp4LacZneo/+ and 
Bmp2
LacZneo/+
 adult mice are dissected at 3 month old.  Hearts are then embedded and 
sectioned (G and J).  Blue is lacZ positive. Scale bar (red)=500 μm, scale bar 
(black)=50μm. ao: aorta; pa: pulmonary. 
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A-5: Abnormal Assembly of SMCs in Bmp and Fbn mutants. (A-D): boxed area is 
higher magnification. Scale bar =20 μm.  
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A-6: Bmp deficiency results in abnormal truncus morphology. (A-J): morphology of 
different compound mutants of Bmp. panel B, D, F, H, J are zoomed-in images of panel 
A, C, E, G, I, respectively.  Arrows in D, F, H show abnormal morphology of trunks 
vessel wall in Bmp mutants. Arrowheads in J show mild phenotype comparing to D, F, 
and H. Scale bar (white)= 100 μm; Scale bar (red)=50 μm. 
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A-7: Fbn-1 expression is not affected in the absence of Bmp4/7.  (A-D): 
Immunostaining of Fbn-1 on Bmp4/7 dCKO at E14.5. Scale bar (white) =100 μm; Scale 
bar (red) = 50 μm.  
 
 
86 
 
 
A-8: Putative Smad binding sites in Fbn upstream sequence. Smad binding elements 
sequence CAGAC/GTCTG are conserved among several species. Smad1 binding site 
sequence is ATGC, and GC rich box is GCCG.  
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A-9: miR-17-92 overexpression represses Isl-1. Arrow heads point to Isl-1 positive 
cells. Middle panel is zoomed-in images of white boxed area, right panel is zoomed-in 
images of blue boxed area. Scale bar (red)=100 μm; purple=50 μm.  
